Travere Therapeutics, Inc. (0001438533) (Filer) — SEC 8-K Filing
Travere Therapeutics
May 11, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
NorthEdge-backed Latus Group has acquired Euro Environmental, an occupational hygiene provider based in Doncaster. Euro Environmental delivers workplace exposure monitoring, indoor air quality testing, and noise assessments, plus related compliance services for organisations across the UK.
The acquisition is Latus Group’s fourth since NorthEdge’s initial investment in July 2024. Latus said the deal supports continued growth of its Hygiene division, which has recorded year-on-year growth of 50%. Latus also provides occupational health, health surveillance, and wellbeing services, and will position Euro Environmental to strengthen end-to-end workplace health offerings nationally.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Travere Therapeutics
May 11, 2026
Pharvaris
May 11, 2026
Partner Therapeutics→Bizengri (bispecific antibody)
May 11, 2026
The Surgery Center of Southern Oregon
May 11, 2026
Mobia Medical
May 11, 2026